Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome

Mediators of Inflammation

Volumn 2007, Issue , 2007, Pages

  Saltevo, Juha ^a   Vanhala, Mauno ^a,b   Kautiainen, Hannu ^c   Kumpusalo, Esko ^d,e   Laakso, Markku ^d  

^a Central Hospital of Middle Finland   (Finland)

^b Laukaa Health Center   (Finland)

^c Medcare Foundation   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; WAIST CIRCUMFERENCE; AGED; BIOSYNTHESIS; BLOOD; INFLAMMATION; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 36949028962     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2007/93573     Document Type: Article

References (45)

1. World Health Orgnization Definition, diagnosis and classification of diabetes mellitus and its complications. World Health Orgnization Geneva, Switzerland 99.2 1999
2. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel ondetection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 285 19 2001 2486 2497
3. S. M. Grundy B. Hansen S. C. Smith Jr. J. I. Cleeman R. A. Kahn Clinical management of metabolic syndrome: report of the American heart association/national heart, lung,and blood institute/American diabetes association conference on scientific issues related to management. Circulation 109 4 2004 551 556
4. International Diabetes Federation The IDF consensus worldwide definition of the metabolic syndrome. October 2005, http://www.idf.org/webdata/docs/ metac_syndrome_def.pdf
5. K. G. M. M. Alberti P. Zimmet J. Shaw The metabolic syndrome: a new worldwide definition. The Lancet 366 9491 2005 1059 1062
6. C. Weyer T. Funahashi S. Tanaka Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology & Metabolism 86 5 2001 1930 1935
7. Y. Matsuzawa Adipocytokines and metabolic syndrome. Seminars in Vascular Medicine 5 1 2005 34 39
8. T. Kadowaki T. Yamauchi Adiponectin and adiponectin receptors. Endocrine Reviews 26 3 2005 439 451
9. J. C. Pickup M. A. Crook Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41 10 1998 1241 1248
10. A. J. G. Hanley A. Festa R. B. D'Agostino Jr. Metabolic and inflammation variable clusters and prediction of type 2 diabetes:factor analysis using directly measured insulin sensitivity. Diabetes 53 7 2004 1773 1781
11. P. M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 3 2003 363 369
12. D. E. Laaksonen L. Niskanen K. Nyyssönen K. Punnonen T.-P. Tuomainen J. T. Salonen C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men:a population-based cohort study. European Heart Journal 26 17 2005 1783 1789
13. M. Soinio minna.soinio@tyks.fi J. Marniemi M. Laakso S. Lehto T. Rönnemaa High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. Diabetes Care 29 2 2006 329 333
14. D. E. Laaksonen L. Niskanen K. Nyyssönen Kristiina.Nyyssonen@uku.fi C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 8 2004 1403 1410
15. A. D. Pradhan J. E. Manson N. Rifai J. E. Buring P. M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association 286 3 2001 327 334
16. P. M. Ridker N. Rifai L. Rose J. E. Buring N. R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of firstcardiovascular events. The New England Journal of Medicine 347 20 2002 1557 1565
17. N. Sattar A. Gaw O. Scherbakova Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in thewest of Scotland coronary prevention study. Circulation 108 4 2003 414 419
18. M. Hassinen T. A. Lakka P. Komulainen H. Gylling A. Nissinen R. Rauramaa C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care 29 4 2006 931 932
19. S. M. Haffner The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. The American Journal of Cardiology 97 2, supplement 1 2006 3 11
20. P. M. Ridker pridker@partners.org C-reactive protein, inflammation, and cardiovascular disease: clinical update. Texas Heart Institute Journal 32 3 2005 384 386
21. C. Gabay I. Kushner Acute-phase proteins and other systemic responses to inflammation. The New England Journal of Medicine 340 6 1999 448 454
22. U. Salmenniemi E. Ruotsalainen J. Pihlajamäki Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin,cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 25 2004 3842 3848
23. G. Patti A. D'Ambrosio A. Dobrina Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. Journal of Thrombosis and Thrombolysis 14 2 2002 139 143
24. A. Katz S. S. Nambi K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology & Metabolism 85 7 2000 2402 2410
25. P. H. Westfall R. D. Tobias D. Rom R. D. Wolfinger Y. Hochberg Multiple Comparisons and Multiple Tests Using the SAS System. SAS Institute Cary, NC, USA 1999
26. J. R. Landis G. G. Koch The measurement of observer agreement for categorical data. Biometrics 33 1 1977 159 174
27. M.-S. Lin S.-R. Shih H.-Y. Li Serum C-reactive protein levels correlates better to metabolic syndrome defined by international diabetes federation than by NCEP ATP III in men. Diabetes Research and Clinical Practice 77 2 2007 286 292
28. C. Lorenzo lorenzo@uthscsa.edu K. Williams K. J. Hunt S. M. Haffner The national cholesterol education program-adult treatment panel III, international diabetes federation,and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular diseaseand diabetes. Diabetes Care 30 1 2007 8 13
29. Y. Okamoto S. Kihara T. Funahashi Y. Matsuzawa P. Libby Adiponectin: a key adipocytokine in metabolic syndrome. Clinical Science 110 3 2006 267 278
30. S. E. Kahn B. Zinman S. M. Haffner Obesity is a major determinant of the association of C-reactive protein levels and the metabolicsyndrome in type 2 diabetes. Diabetes 55 8 2006 2357 2364
31. J.-P. Després jean-pierre.despres@crhl.ulaval.ca Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. European Heart Journal Supplements 8, supplement B 2006 B4 B12
32. Y. Wang youfwang@uic.edu E. B. Rimm M. J. Stampfer W. C. Willett F. B. Hu Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. American Journal of Clinical Nutrition 81 3 2005 555 563
33. M. A. Banerji banerm05@hscbklyn.edu N. Faridi R. Atluri R. L. Chaiken H. E. Lebovitz Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. Journal of Clinical Endocrinology & Metabolism 84 1 1999 137 144
34. A. Festa festa@magnet.at R. D'Agostino Jr. G. Howard L. Mykkänen R. P. Tracy S. M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome:the insulin resistance atherosclerosis study (IRAS). Circulation 102 1 2000 42 47
35. S. Ishikawa i-shizu@jichi.ac.jp K. Kayaba T. Gotoh Y. Nakamura E. Kajii Metabolic syndrome and C-reactive protein in the general population: JMS cohort study. Circulation Journal 71 1 2007 26 31
36. M. Santaniemi merja.santaniemi@oulu.fi Y. A. Kesäniemi O. Ukkola Low plasma adiponectin concentration is an indicator of the metabolic syndrome. European Journal of Endocrinology 155 5 2006 745 750
37. K. Matsushita K. Tamakoshi H. Yatsuya Further inflammatory information on metabolic syndrome by adiponectin evaluation. preprint, International Journal of Cardiology, 2007
38. F. M. Adam M. J. Nara J. M. Adam Fasting insulin, adiponectin, hs-CRP levels and the components of metabolic syndrome. Acta Medica Indonesiana 38 2006 4 179 184
39. G. Q. Shaibi M. L. Cruz M. J. Weigensberg Adiponectin independently predicts metabolic syndrome in overweight Latino youth. Journal of Clinical Endocrinology & Metabolism 92 5 2007 1809 1813
40. C. Herder M. Peltonen W. Koenig Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes. Diabetes 55 8 2006 2340 2346
41. E. Ruotsalainen U. Salmenniemi I. Vauhkonen Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care 29 12 2006 2714 2720
42. W. P. Arend C. Gabay Physiologic role of interleukin-1 receptor antagonist. Arthritis Research 2 4 2000 245 248
43. P. Ilanne-Parikka J. G. Eriksson J. Lindström Prevalence of the metabolic syndrome and its components: findings from a Finnishgeneral population sample and the Diabetes Prevention Study cohort. Diabetes Care 27 9 2004 2135 2140
44. C. Lara-Castro larac@uab.edu N. Luo P. Wallace R. L. Klein W. T. Garvey Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55 1 2006 249 259
45. K. Hara M. Horikoshi T. Yamauchi Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulinresistance and metabolic syndrome. Diabetes Care 29 6 2006 1357 1362